Edward Pratt

13PUBLICATIONS
20CO-AUTHORS
PharmacogenomicsEconometric and statistical methodsPharmaceutical delivery technologiesFood properties (incl. characteristics and health benefits)Experimental methods in fluid flow, heat and mass transfer
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 02, 2026
Insulin Sensitivity and Beta Cell Function With Macupatide Alone or With Dulaglutide in Type 2 Diabetes: A Phase 1b, Randomised Controlled Trial.

|Feb 23, 2026
Characterisation of steady-state pharmacokinetics and glucodynamics of once-weekly insulin efsitora alfa in individuals with type 2 diabetes.

Jennifer Leohr, Oliver Klein, Tim Heise

|Jan 21, 2026
Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept.

Shobha Bhattachar, Lai San Tham, Beth Tidemann-Miller

|Aug 28, 2025
Impact of tirzepatide treatment on participant-reported food craving and food preference: Secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction.

Sam F Kennedy, Alastair Knights, Eric Ravussin

|Jun 24, 2025
Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial.

Corby K Martin, Owen T Carmichael, Susan Carnell

|Aug 27, 2024
A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy.

Filip K Knop, Shweta Urva, Mallikarjuna Rettiganti

Pageof 3

Frequent Collaborators

9 joint publications

Axel Haupt

6 joint publications

Tamer Coskun

4 joint publications

Kieren J Mather

3 joint publications

Tim Heise